[Retracted] Clinical Observation and Pharmacoeconomic Evaluations of Original Research Drug and Generic Drug Bortezomib in the Treatment of Multiple Myeloma

Table 2

Comparison of treatment efficacy and safety in included patients.

Treatment cycle	Original research drug group			Generic drug group
	>=VGPR	Sample	Total efficacy rate (%)	>=VGPR	Sample	Total efficacy rate (%)
1	20 (0.13)	149	13.42	22 (0.18)	120	18.33	0.270
2	44 (0.30)	149	29.53	31 (0.26)	120	25.83	0.501
3	80 (0.54)	147	54.42	65 (0.57)	114	57.02	0.676
4	92 (0.66)	139	66.19	75 (0.71)	105	71.43	0.383
5	91 (0.66)	137	66.42	69 (0.73)	95	72.63	0.315
6	90 (0.67)	134	67.16	71 (0.79)	90	78.89	0.056